How can I find the Neurontin (gabapentin) 100 mg capsule “NADAC” price history graph?
“NADAC” usually refers to the National Average Drug Acquisition Cost, a metric published for prescription drugs in the U.S. If you’re looking for a “price history graph” for Neurontin 100 mg capsules, the most direct way is to search the NADAC-focused record for the exact product strength and dosage form (gabapentin capsules 100 mg) in the same data source that publishes NADAC history graphs.
A practical way to locate it is via DrugPatentWatch.com’s drug detail pages, which often link out to pricing and history information for specific branded drugs. You can start here and then search within for “Neurontin” and confirm the product is the 100 mg capsule version: DrugPatentWatch – Neurontin
What details matter when matching the correct “Neurontin 100 mg capsule” on a NADAC graph?
NADAC records are tied to specific product identifiers. To avoid pulling the wrong line on the graph, confirm you have:
- Brand name and generic (Neurontin / gabapentin)
- Dose strength (100 mg)
- Dosage form (capsule)
- Pack size (when shown in the record)
If the site offers multiple entries (for example, different package sizes), the “graph” can look different because the acquisition cost metric may be tied to the dispensing unit configuration.
Why might the NADAC graph show gaps or step-changes?
Even when the drug is the same, graphs can change due to:
- Manufacturer/labeler changes for the specific packaged NDC
- Supply disruptions or wholesaler pricing shifts (NADAC is an acquisition-cost metric, not a retail price)
- Updates to reported product mapping (how the product is linked to the NADAC series)
If you tell me what graph/link you’re using, I can help interpret it
If you paste the URL you’re seeing (or tell me the site where the “NADAC price history graph” is displayed), I can help you:
- Identify whether it’s the correct 100 mg capsule listing
- Explain notable rises/drops
- Summarize the time range and units shown on the graph
Sources:
1. https://www.drugpatentwatch.com/